N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide

C18H15N5O — CID 162638492

IUPACN-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide
SMILESO=C(NCc1ccc(-n2cncn2)cc1)c1ccc2ccccn12
InChIInChI=1S/C18H15N5O/c24-18(17-9-8-15-3-1-2-10-22(15)17)20-11-14-4-6-16(7-5-14)23-13-19-12-21-23/h1-10,12-13H,11H2,(H,20,24)
InChIKeyAJHUMUBRYZLJRM-UHFFFAOYSA-N
MW317.35 g/mol
LogP2.45
Rot. Bonds4

About N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide

N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide (PubChem CID 162638492) has the molecular formula C18H15N5O and a molecular weight of 317.35 g/mol. Its IUPAC name is N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide.

Molecular Properties

Compound NameN-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide
PubChem CID162638492
Molecular FormulaC18H15N5O
Molecular Weight317.35 g/mol
Exact Mass317.13
IUPAC NameN-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide
SMILESO=C(NCc1ccc(-n2cncn2)cc1)c1ccc2ccccn12
InChIInChI=1S/C18H15N5O/c24-18(17-9-8-15-3-1-2-10-22(15)17)20-11-14-4-6-16(7-5-14)23-13-19-12-21-23/h1-10,12-13H,11H2,(H,20,24)
InChIKeyAJHUMUBRYZLJRM-UHFFFAOYSA-N
XLogP2.45
TPSA64.22 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500317.35
LogP ≤ 52.45
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3,5-dichloro-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]pyridine-4-carboxamide
CID 167814570
3-amino-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]propanamide;hydrochloride
CID 119295872
2-phenylsulfanyl-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]acetamide
CID 167764922
3-phenoxy-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]benzamide
CID 55732141
1-[[(1R,2S)-2-phenylcyclopropyl]methyl]-3-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]urea
CID 97081623
2-amino-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]propanamide;hydrochloride
CID 119295878
2-ethyl-3-methyl-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]quinoline-4-carboxamide
CID 71893303
N-[[4-(4-fluorophenoxy)phenyl]methyl]-4-(1,2,4-triazol-1-yl)benzamide
CID 24535888
1-(2-imidazo[1,2-a]pyridin-2-ylethyl)-3-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]urea
CID 55922211
3-hydroxy-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]piperidine-1-carboxamide
CID 110901464
1-[[(1S,2R)-2-methylcyclopropyl]methyl]-3-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]urea
CID 97313536
5-ethyl-N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]-1H-pyrazole-3-carboxamide
CID 78899603

Frequently Asked Questions

What is the IUPAC name of N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide?
The IUPAC name of N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide (CID 162638492) is N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide.
What is the SMILES notation for N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide?
The canonical SMILES for N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide is O=C(NCc1ccc(-n2cncn2)cc1)c1ccc2ccccn12.
What is the InChIKey of N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide?
The InChIKey is AJHUMUBRYZLJRM-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H15N5O/c24-18(17-9-8-15-3-1-2-10-22(15)17)20-11-14-4-6-16(7-5-14)23-13-19-12-21-23/h1-10,12-13H,11H2,(H,20,24).
What are the key properties of N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide?
N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide has a molecular weight of 317.35 g/mol, XLogP of 2.45, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-(1,2,4-triazol-1-yl)phenyl]methyl]indolizine-3-carboxamide is sourced from PubChem (CID 162638492), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).